Zai Lab President Sells $174k in Stock via 10b5-1 Plan
Zai Lab Ltd
Subscribe to track ZLAB
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Zai Lab President Sells $174k in Stock via 10b5-1 Plan
Company: Zai Lab Ltd (ZLAB) Form: 4 | Filed: 2026/03/05 Significance: Low
Insider: Amado Rafael Title: President, Head of Global Oncology Research and Development Relationship: Officer
Transaction: • Type: Sale (Rule 10b5-1) • Shares: 10,000 ADS • Price: $17.38 • Value: $173,800 • Owned After: 42,391
Key Insight: Routine sale representing ~19% of the insider's reported holdings, executed under a pre-arranged trading plan. Transaction value is negligible relative to the company's $16.3B market cap.
Market Context: Transaction occurred pursuant to a 10b5-1 plan adopted in November 2025.
Comprehensive Analysis
SEC Filing Analysis: Zai Lab Ltd (ZLAB)
Executive Summary
- Trading Significance: Low
- Key Takeaway: President Rafael Amado executed a planned sale of $173,800 in ADS, representing a negligible fraction of the company's market capitalization.
- Market Impact: Neutral - The transaction volume is too small to impact the stock price of a $16.3B company.
Company Information
| Field | Value |
|---|---|
| Company | Zai Lab Ltd |
| Ticker Symbol | ZLAB |
| CIK | 0001704292 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Amado Rafael |
| CIK | 0001662119 |
| Title/Position | President, Head of Global Oncology Research and Development |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-03 |
| Transaction Code | S (Sale) |
| Security Type | American Depositary Shares |
| Shares Involved | 10,000 |
| Price Per Share | $17.38 |
| Total Value | $173,800 |
| Shares Owned After | 42,391 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $173,800 |
| % of Market Cap | ~0.001% |
| Shares Transacted | 10,000 |
| % of Shares Outstanding | ~0.0009% |
| Post-Transaction Ownership | 42,391 shares (~0.004% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $16.30 billion, a $173k transaction is mathematically insignificant.
- Ownership Concentration: The insider retains 42,391 ADS following the sale. The sale represents approximately 19% of their reported direct holdings.
- Transaction Significance: The transaction constitutes less than 0.001% of the market cap and shares outstanding, indicating no broader liquidity impact.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale was conducted under a Rule 10b5-1 trading plan adopted on November 15, 2025, removing the implication of timing based on current non-public information. The size is too small to affect price action.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral. Executive sales for tax planning or diversification are common and this volume is minimal.
Additional Context
Transaction Notes
- Special Circumstances: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2025.
- Security Note: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.